奇洛斯塔的基因保护作用减轻了人体培养血淋巴细胞中卡巴马西平诱导的基因毒性
Enaam M Al Momany1, Abeer M Rababa'h2, Karem H Alzoubi3,4
1Department of Clinical Pharmacy and Pharmacy Practice, Faculty of Pharmaceutical Sciences, The Hashemite University, P.O. box 330127, Zarqa 13133, Jordan.
Toxicology reports
|December 10, 2024
概括
奇洛斯塔可能会保护人体淋巴细胞免受卡巴马泽毒性的影响. 这项研究发现,西洛斯塔减少了卡巴马西平诱导的基因毒性,并使人类血液淋巴细胞中的细胞增殖正常化.
科学领域:
- 药理学 药理学是指药理学的学科.
- 毒理学 毒理学 毒理学
- 细胞生物学 细胞生物学
背景情况:
- 卡巴马泽平是一种广泛使用的抗药物,已知具有细胞毒性.
- 基洛斯塔是一种抗血小板剂,具有抗氧化,抗炎和抗瘤的特性.
研究的目的:
- 调查卡巴马泽和西洛斯塔对人类淋巴细胞的基因毒性和细胞毒性作用.
- 为了确定结合卡巴马泽和西洛斯塔对这些细胞效应的影响.
主要方法:
- 通过姐妹染色体交换 (SCE) 试验评估的基因毒性.
- 细胞毒性通过细胞动力学测试进行评估,包括线粒体和增殖指数.
主要成果:
- 卡巴马西平显著增加了SCE和细胞增殖.
- 奇洛斯塔显著降低了SCE频率和细胞增殖.
- 结合两种药物使SCE频率和增殖指数正常化到控制水平.
结论:
- 锡洛斯塔显示出对人类淋巴细胞中卡巴马泽诱导的基因毒性和细胞毒性具有潜在的保护作用.
- 组合疗法可以减轻卡巴马西平对细胞的不良影响.
相关概念视频
Mutagenicity and Carcinogenicity
1.2K
Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
1.2K
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Drugs that Stabilize Microtubules
2.0K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.0K
DNA Damage can Stall the Cell Cycle
9.0K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.0K
Drugs that Destabilize Microtubules
1.9K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
1.9K


